A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study

Clinical trial NCT02049112 · COMPLETED

Trial details

NCT number: NCT02049112
Sponsor: Unither Pharmaceuticals, France
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Xerostomia Hyposalivation Head and Neck Cancer Sjögren Syndrome

Start date: 2012-01-01
Primary completion: 2013-04-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.